Brief Acceptance and Commitment Therapy for Fibromyalgia: Feasibility and Effectiveness of a Replicated Single-Case Design
Table 2
Demographic characteristics, nonoverlap calculations, average baseline scores, and compliance with the app.
Patient
Demographic characteristics
Treatment condition
Interference with sleep
Interference with social activities
Fatigue
Sadness
Pain intensity
Compliance with the app
Age
Education
Job status
NAP (%)
Baseline
NAP (%)
Baseline
NAP (%)
Baseline
NAP (%)
Baseline
NAP (%)
Baseline
Morning (%)
Evening (%)
1
67
Primary
Homemaker
Group
9
8.8
33
4.2
49
4.4
20
4.3
25
5.9
59.5
57.1
2
65
Primary
Homemaker
Group
2
4.2
62
4.8
17
6.7
13
5.6
13
6.1
69.0
69.0
3
53
Primary
Working
Group
48
5.6
31
5.0
35
6.2
64
5.2
38
5.9
57.1
61.9
4
54
Secondary
Unemployed
Group
50
5.0
22
4.8
47
7.8
58
6.9
38
6.9
57.1
64.3
5
67
Primary
TPD
Individual
49
3.2
62
1.4
41
5.9
53
2.8
55
5.6
66.7
88.1
6
66
Primary
Homemaker
Individual
60
5.0
60
2.0
53
4.3
61
3.7
47
3.7
45.2
59.5
7
62
Secondary
TPD
Individual
0
3.2
35
3.6
42
6.3
27
5.4
51
6.3
73.8
78.6
NAP: percentage of nonoverlap of all pairs; TPD: total permanent disability. Compared to previously reported nonoverlap indices [38], results should be tentatively interpreted as follows: <38%: poor effect; 38% to 68%: mild-to-moderate effect; 69% to 96%: moderate-to-large effect; >96%: very large effect. Baseline scores refer to the average scores from the first week before treatment onset.
